The contribution of empiricism to antiparasite drug discovery
- 31 December 1994
- journal article
- Published by Elsevier in Parasitology Today
- Vol. 10 (10) , 387-389
- https://doi.org/10.1016/0169-4758(94)90228-3
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Atovaquone — a novel broad-spectrum anti-infective drugParasitology Today, 1993
- Rational drug design, medicinal chemistry, planned serendipity and the impact of automation on the drug discovery processJournal of Analytical Methods in Chemistry, 1993
- Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDSThe Lancet, 1992
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990
- Qinghaosu (Artemisinin): an Antimalarial Drug from ChinaScience, 1985
- Parasite enzymes as potential targets for antiparasitic chemotherapyJournal of Medicinal Chemistry, 1984
- Chemotherapy of Theileria parva infectionNature, 1976
- Naphthoquinone Antimalarials. XXIX. 2-Hydroxy-3-(ω-cyclohexylalkyl)-1,4-naphthoquinonesJournal of Medicinal Chemistry, 1967
- Novel Broad-Spectrum Anthelmintics. Tetramisole1 and Related Derivatives of 6-Arylimidazo[2,1-b]thiazoleJournal of Medicinal Chemistry, 1966
- Naphthoquinone Antimalarials. II. Correlation of Structure and Activity Against P. lophurae in Ducks1Journal of the American Chemical Society, 1948